DURHAM – TARGET PharmaSolutions a real-world data solutions company for the pharmaceutical and biotech industries, has appointed Neal Bibeau as CEO, effective immediately. The company also appointed Franz B. Humer, Ph.D. as senior advisor.
Meg Powell, PharmD, TARGET board chair and co-founder, said in a statement, “Neal Bibeau is a seasoned health care technology executive who has delivered innovative, real-world data solutions for the life sciences industry, driving growth and value for all stakeholders. He most recently built Symphony Health into a leading data and analytics company and his background in data management and healthcare will accelerate our development of real-world data that answer pressing questions in healthcare and drug development.”
Humer is the former CEO and chair of Roche Holding, Ryan Harris, M.D., TARGET board member and general partner at Norwest Venture Partners, said, “Humer brings years of industry expertise to TARGET and is a proven asset as we further expand our clinical data disease categories and grow our overall platform. We look forward to his contributions to TARGET’s success in the real-world evidence ecosystem.”
